UPDATE 1-AstraZeneca trumpets standalone strength in drug development
November 18, 2014 at 03:12 AM EST
* Investor day comes 8 days before Pfizer can resume pursuit (Adds filing brought forward for cancer pill, long-term forecast reiterated, further details)